22 nd Century Group (NASDAQ:XXII) is developing another reduced nicotine cigarette, with a goal to receive approval from the U.S. Food and Drug Administration by the end of this year. Dubbed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback